WP6 Managing Frailty At Individual Level
The main focus of WP6 is to propose good practice guidelines on how nutrition, drugs, physical exercise and ICTs can help to prevent, delay the onset or manage frailty at individual level in the Member States (MSs) of the European Union. Each of these factors will be carefully analysed:
– Prevention: WP6 will identify, at individual, social and environmental level, what can help or harm people, who are frail or at risk of frailty. Aspects such as communication, social inequalities, working conditions, gender and living conditions will be taken into consideration. Positive examples, common key success factors and the appropriate age to start the frailty prevention will be identified.
– Clinical management: staring from positive models of management of frail older people in the MSs, common key success factors will be analysed to help construct the optimal clinical management plan. The aim is to improve clinical treatment coordination and patient-centered care, as well as to ensure holistic healthcare. This should reduce nursing home placement, hospitalization, length of hospital stay and costs, and improve patients’ satisfaction.
– Nutrition: WP6 will analyze the risks of inappropriate diet in primary care settings, hospitals, clinics and community services for older people, increasing the risk of onset or worsening of frailty at individual level. . Further on, the WP will identify the examples of good practices in the participant MS on determinants of diets (nutrition) as primary prevention of frailty, and on special dietary requirements for chronic diseases (e.g. diabetes, osteoporosis). WP will as well identify the methods and indicators of pre-frailty related to nutrition that might be used in primary health care settings and/or health promotion activities (e.g. cholesterol, glucose, lipids blood levels).
– Physical exercise: A comprehensive approach for physical activity among the ageing population will be developed. The final product will be guidelines containing relevant suggestions for policymakers, practitioners and training institutions, containing a number of high impact potential interventions and suggestions on physical activity for the ageing population.
– Drugs: WP6 will map current policy and practice in the participating MSs, to identify transnational learning on pharmaceutical care for frailty and multimorbid people. Further on, current policies, programmes, guidelines and good practices will be identified, and transferability and potential for scaling up models of pharmaceutical care assessed. Case studies that describe the impact on people’s care experience and outcomes will be gathered.
– ICTs: WP6 will map and analyze the existing ICT tools and Apps taking into account the frailty prevention, screening and support, as well as frailty detection, diagnosis, treatment and/or monitoring in clinical practice and ICT tools and Apps that increase resilience and help to maintain function and activities of daily life. Mapping and analyzing will be followed by the assessment of ICT tools and Apps integration and interoperability with corporate information systems (electronic health record and others), as well as by identifying the examples of good practices that describe success and effective stories.
WP6 results will be discussed in an Expert Panel (EP) meeting to draw conclusions and refine content. Following the EP comments, a state of the art report (SoAR) describing the Management of Frailty at Individual Level will be finalised. The SoAR will be subsequently incorporated into the final Frailty Prevention Approach (FPA) document.